353 related articles for article (PubMed ID: 31196016)
1. Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.
Nashabat M; Obaid A; Al Mutairi F; Saleh M; Elamin M; Ahmed H; Ababneh F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Aljeraisy M; Hussein MA; Alasmari A; Alfadhel M
BMC Pediatr; 2019 Jun; 19(1):195. PubMed ID: 31196016
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial.
Alfadhel M; Nashabat M; Saleh M; Elamin M; Alfares A; Al Othaim A; Umair M; Ahmed H; Ababneh F; Al Mutairi F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Almannai M; Aljeraisy M; Albdah B; Hussein MA; Rahbeeni Z; Alasmari A
Orphanet J Rare Dis; 2021 Oct; 16(1):422. PubMed ID: 34635114
[TBL] [Abstract][Full Text] [Related]
3. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study.
Valayannopoulos V; Baruteau J; Delgado MB; Cano A; Couce ML; Del Toro M; Donati MA; Garcia-Cazorla A; Gil-Ortega D; Gomez-de Quero P; Guffon N; Hofstede FC; Kalkan-Ucar S; Coker M; Lama-More R; Martinez-Pardo Casanova M; Molina A; Pichard S; Papadia F; Rosello P; Plisson C; Le Mouhaer J; Chakrapani A
Orphanet J Rare Dis; 2016 Mar; 11():32. PubMed ID: 27030250
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.
Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR
Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of carglumic acid in methylmalonic aciduria, propionic aciduria and isovaleric aciduria in Italy: a qualitative survey.
Burlina A; Bettocchi I; Biasucci G; Bordugo A; Gasperini S; La Spina L; Maines E; Meli C; Menni F; Paci S; Procopio E; Rossi A; Rubert L; Spada M; Tubili F; Tummolo A
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5136-5143. PubMed ID: 35916811
[TBL] [Abstract][Full Text] [Related]
6. Use of carglumic acid in the treatment of hyperammonaemia during metabolic decompensation of patients with propionic acidaemia.
Abacan M; Boneh A
Mol Genet Metab; 2013 Aug; 109(4):397-401. PubMed ID: 23791308
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.
Pillai NR; Stroup BM; Poliner A; Rossetti L; Rawls B; Shayota BJ; Soler-Alfonso C; Tunuguntala HP; Goss J; Craigen W; Scaglia F; Sutton VR; Himes RW; Burrage LC
Mol Genet Metab; 2019 Dec; 128(4):431-443. PubMed ID: 31757659
[TBL] [Abstract][Full Text] [Related]
8. A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.
Armstrong AJ; Collado MS; Henke BR; Olson MW; Hoang SA; Hamilton CA; Pourtaheri TD; Chapman KA; Summar MM; Johns BA; Wamhoff BR; Reardon JE; Figler RA
Mol Genet Metab; 2021 May; 133(1):71-82. PubMed ID: 33741272
[TBL] [Abstract][Full Text] [Related]
9. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.
Baumgartner MR; Hörster F; Dionisi-Vici C; Haliloglu G; Karall D; Chapman KA; Huemer M; Hochuli M; Assoun M; Ballhausen D; Burlina A; Fowler B; Grünert SC; Grünewald S; Honzik T; Merinero B; Pérez-Cerdá C; Scholl-Bürgi S; Skovby F; Wijburg F; MacDonald A; Martinelli D; Sass JO; Valayannopoulos V; Chakrapani A
Orphanet J Rare Dis; 2014 Sep; 9():130. PubMed ID: 25205257
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for drug development in propionic and methylmalonic acidemias.
Longo N; Sass JO; Jurecka A; Vockley J
J Inherit Metab Dis; 2022 Mar; 45(2):132-143. PubMed ID: 35038174
[TBL] [Abstract][Full Text] [Related]
11. High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome.
Molema F; Haijes HA; Janssen MC; Bosch AM; van Spronsen FJ; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Fuchs S; Langendonk JG; Rizopoulos D; van Hasselt PM; Williams M
Clin Nutr; 2021 May; 40(5):3622-3630. PubMed ID: 33451859
[TBL] [Abstract][Full Text] [Related]
12. Management of methylmalonic acidemia (MMA) with N-carbamylglutamate: A case report from Italy.
Tubili F; Pochiero F; Curcio MR; Procopio E
Mol Genet Genomic Med; 2023 Jan; 11(1):e2073. PubMed ID: 36331064
[TBL] [Abstract][Full Text] [Related]
13. Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?
Levrat V; Forest I; Fouilhoux A; Acquaviva C; Vianey-Saban C; Guffon N
Orphanet J Rare Dis; 2008 Jan; 3():2. PubMed ID: 18234091
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?
Haijes HA; Molema F; Langeveld M; Janssen MC; Bosch AM; van Spronsen F; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Langendonk JG; Williams M; van Hasselt PM
J Inherit Metab Dis; 2020 May; 43(3):424-437. PubMed ID: 31828787
[TBL] [Abstract][Full Text] [Related]
15. Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.
Armstrong AJ; Henke BR; Collado MS; Taylor JM; Pourtaheri TD; Dillberger JE; Roper TD; Wamhoff BR; Olson MW; Figler RA; Hoang SA; Reardon JE; Johns BA
J Med Chem; 2021 Apr; 64(8):5037-5048. PubMed ID: 33848153
[TBL] [Abstract][Full Text] [Related]
16. Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study.
Yap S; Lamireau D; Feillet F; Ruiz Gomez A; Davison J; Tangeraas T; Giordano V
Drugs R D; 2024 Mar; 24(1):69-80. PubMed ID: 38198106
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and management of organic acidemias in Japan.
Fujisawa D; Nakamura K; Mitsubuchi H; Ohura T; Shigematsu Y; Yorifuji T; Kasahara M; Horikawa R; Endo F
J Hum Genet; 2013 Dec; 58(12):769-74. PubMed ID: 24067294
[TBL] [Abstract][Full Text] [Related]
18. Long-term liver disease in methylmalonic and propionic acidemias.
Imbard A; Garcia Segarra N; Tardieu M; Broué P; Bouchereau J; Pichard S; de Baulny HO; Slama A; Mussini C; Touati G; Danjoux M; Gaignard P; Vogel H; Labarthe F; Schiff M; Benoist JF
Mol Genet Metab; 2018 Apr; 123(4):433-440. PubMed ID: 29433791
[TBL] [Abstract][Full Text] [Related]
19. N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia.
Kasapkara CS; Ezgu FS; Okur I; Tumer L; Biberoglu G; Hasanoglu A
Eur J Pediatr; 2011 Jun; 170(6):799-801. PubMed ID: 21207059
[TBL] [Abstract][Full Text] [Related]
20. N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria.
Filippi L; Gozzini E; Fiorini P; Malvagia S; la Marca G; Donati MA
Neonatology; 2010; 97(3):286-90. PubMed ID: 19887858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
